OMTX-505

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameOMTX-505
Drug Alias NameMTX5-NIG
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionRibosome inactivating proteins modulators
TargetsRibosome inactivating proteins
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncomatryx Biopharma Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncomatryx Biopharma Sl
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A